OppenheimerFunds’s Albany Molecular Research Inc AMRI Stock Holding History

OppenheimerFunds’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-77,496	Closed	-$1.68M	–	1904
2017 Q2	$1.68M	Buy	77,496 +45,889	+145%	+$833K	﹤0.01%	990
2017 Q1	$444K	Buy	31,607 +14,033	+80%	+$230K	﹤0.01%	1547
2016 Q4	$330K	Buy	17,574 +3,398	+24%	+$57.8K	﹤0.01%	1566
2016 Q3	$234K	Buy	14,176 +476	+3%	+$7.05K	﹤0.01%	1593
2016 Q2	$184K	Buy	13,700 +1,950	+17%	+$28.4K	﹤0.01%	1630
2016 Q1	$180K	Buy	+11,750	New	+$184K	﹤0.01%	1617
2014 Q4	–	Sell	-327,360	Closed	-$7.22M	–	991
2014 Q3	$7.22M	Buy	+327,360	New	+$6.7M	0.01%	804

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

OppenheimerFunds's AMRI Position: Q3 2017 in Review

OppenheimerFunds sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 77,496 shares — an estimated $1.68M sold.

OppenheimerFunds first reported a position in AMRI in Q3 2014 and held it in 7 quarters. The position peaked at $7.22M in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

OppenheimerFunds reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
OppenheimerFunds sold 77,496 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.68M.
OppenheimerFunds first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 7 quarters.
OppenheimerFunds's Albany Molecular Research Inc position peaked at $7.22M in Q3 2014.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on OppenheimerFunds's 13F filing for Q3 2017, filed 13 Nov 2017.